Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	cytoskeletal motor activity	DNAH3 DNAH10 MYO6 KIF26A KIF26B DNAH9	2.79e-06	118	67	6	GO:0003774
GeneOntologyMolecularFunction	microtubule motor activity	DNAH3 DNAH10 KIF26A KIF26B DNAH9	3.74e-06	70	67	5	GO:0003777
GeneOntologyMolecularFunction	calcium ion binding	ESYT3 THBS2 MYL2 CLXN MACF1 CASQ2 PLCB2 ADGRV1 MYL10 PKDREJ RYR1 ATP5F1B	6.40e-06	749	67	12	GO:0005509
GeneOntologyMolecularFunction	dynein intermediate chain binding	DNAH3 DNAH10 DNAH9 HTT	7.03e-06	37	67	4	GO:0045505
GeneOntologyMolecularFunction	minus-end-directed microtubule motor activity	DNAH3 DNAH10 DNAH9	2.84e-05	18	67	3	GO:0008569
GeneOntologyMolecularFunction	enzyme regulator activity	STARD13 USP14 CPAMD8 SERPINA1 RAP1GAP GCLM PPP1R3B TRMT112 ATG13 ARHGAP12 EIF2B2 GCGR DENND1C ADGRV1 MCF2L	5.62e-05	1418	67	15	GO:0030234
GeneOntologyMolecularFunction	dynein light intermediate chain binding	DNAH3 DNAH10 DNAH9	1.11e-04	28	67	3	GO:0051959
GeneOntologyMolecularFunction	ATP-dependent activity	ATP5PF DNAH3 DNAH10 MYO6 KIF26A KIF26B MACF1 DNAH9 ATP5F1B	2.02e-04	614	67	9	GO:0140657
GeneOntologyMolecularFunction	phosphatidylinositol binding	ESYT3 STAM2 CGAS DENND1C STAM MCF2L	6.65e-04	316	67	6	GO:0035091
GeneOntologyMolecularFunction	ATP hydrolysis activity	ATP5PF DNAH3 DNAH10 KIF26A MACF1 DNAH9 ATP5F1B	6.78e-04	441	67	7	GO:0016887
GeneOntologyMolecularFunction	nucleoside-triphosphatase regulator activity	STARD13 RAP1GAP ARHGAP12 EIF2B2 GCGR DENND1C MCF2L	1.52e-03	507	67	7	GO:0060589
GeneOntologyMolecularFunction	GTPase regulator activity	STARD13 RAP1GAP ARHGAP12 EIF2B2 GCGR DENND1C MCF2L	1.52e-03	507	67	7	GO:0030695
GeneOntologyMolecularFunction	lipid binding	STARD13 ESYT3 TARDBP STAM2 CGAS PLCB2 DENND1C STAM PPARG MCF2L	1.60e-03	988	67	10	GO:0008289
GeneOntologyMolecularFunction	proton-transporting ATP synthase activity, rotational mechanism	ATP5PF ATP5F1B	1.64e-03	18	67	2	GO:0046933
GeneOntologyCellularComponent	ESCRT-0 complex	STAM2 STAM	3.03e-05	3	67	2	GO:0033565
GeneOntologyCellularComponent	axoneme	SPATA7 DNAH3 CLXN DNAH10 DNAH9 AK8	5.29e-05	207	67	6	GO:0005930
GeneOntologyCellularComponent	ciliary plasm	SPATA7 DNAH3 CLXN DNAH10 DNAH9 AK8	5.44e-05	208	67	6	GO:0097014
GeneOntologyCellularComponent	axonemal dynein complex	DNAH3 DNAH10 DNAH9	6.88e-05	25	67	3	GO:0005858
GeneOntologyCellularComponent	plasma membrane bounded cell projection cytoplasm	SPATA7 DNAH3 CLXN DNAH10 DNAH9 AK8 HTT	6.89e-05	317	67	7	GO:0032838
GeneOntologyCellularComponent	cytoplasmic region	SPATA7 DNAH3 CLXN DNAH10 DNAH9 AK8 HTT	1.52e-04	360	67	7	GO:0099568
GeneOntologyCellularComponent	junctional membrane complex	CASQ2 RYR1	3.59e-04	9	67	2	GO:0030314
GeneOntologyCellularComponent	junctional sarcoplasmic reticulum membrane	CASQ2 RYR1	4.48e-04	10	67	2	GO:0014701
GeneOntologyCellularComponent	inner dynein arm	DNAH3 DNAH10	4.48e-04	10	67	2	GO:0036156
GeneOntologyCellularComponent	dynein complex	DNAH3 DNAH10 DNAH9	6.94e-04	54	67	3	GO:0030286
GeneOntologyCellularComponent	motile cilium	DNAH3 CFAP300 CLXN DNAH10 DNAH9 AK8	9.60e-04	355	67	6	GO:0031514
GeneOntologyCellularComponent	9+2 motile cilium	DNAH3 CLXN DNAH10 DNAH9 AK8	9.98e-04	238	67	5	GO:0097729
MousePheno	paralysis	USP14 TARDBP CLCN1 VPS54 RYR1 HTT	8.54e-06	119	57	6	MP:0000753
MousePheno	increased susceptibility to malignant hyperthermia	RYR1 HTT	1.63e-05	2	57	2	MP:0020214
MousePheno	premature death	USP14 TARDBP THBS2 MYL2 CLCN1 GNE KIF26A VPS54 PRKDC STAM PPARG SIRT1 RYR1 HTT	6.09e-05	1051	57	14	MP:0002083
Domain	Dynein_heavy_chain_D4_dom	DNAH3 DNAH10 DNAH9	1.56e-05	14	67	3	IPR024317
Domain	Dynein_HC_stalk	DNAH3 DNAH10 DNAH9	1.56e-05	14	67	3	IPR024743
Domain	Dynein_heavy_dom-2	DNAH3 DNAH10 DNAH9	1.56e-05	14	67	3	IPR013602
Domain	DHC_N2	DNAH3 DNAH10 DNAH9	1.56e-05	14	67	3	PF08393
Domain	MT	DNAH3 DNAH10 DNAH9	1.56e-05	14	67	3	PF12777
Domain	AAA_8	DNAH3 DNAH10 DNAH9	1.56e-05	14	67	3	PF12780
Domain	ATPase_dyneun-rel_AAA	DNAH3 DNAH10 DNAH9	1.56e-05	14	67	3	IPR011704
Domain	AAA_5	DNAH3 DNAH10 DNAH9	1.56e-05	14	67	3	PF07728
Domain	DHC_fam	DNAH3 DNAH10 DNAH9	1.95e-05	15	67	3	IPR026983
Domain	Dynein_heavy_dom	DNAH3 DNAH10 DNAH9	1.95e-05	15	67	3	IPR004273
Domain	Dynein_heavy	DNAH3 DNAH10 DNAH9	1.95e-05	15	67	3	PF03028
Domain	-	MYL2 CLXN MACF1 PLCB2 MYL10 RYR1	3.44e-04	261	67	6	1.10.238.10
Domain	DHC_N1	DNAH10 DNAH9	3.50e-04	8	67	2	PF08385
Domain	Dynein_heavy_dom-1	DNAH10 DNAH9	3.50e-04	8	67	2	IPR013594
Domain	VHS	STAM2 STAM	4.49e-04	9	67	2	PF00790
Domain	VHS	STAM2 STAM	4.49e-04	9	67	2	PS50179
Domain	VHS	STAM2 STAM	4.49e-04	9	67	2	SM00288
Domain	VHS_dom	STAM2 STAM	4.49e-04	9	67	2	IPR002014
Domain	ITAM_1	STAM2 STAM	5.60e-04	10	67	2	PS51055
Domain	Phos_immunorcpt_sig_ITAM	STAM2 STAM	5.60e-04	10	67	2	IPR003110
Domain	EF-hand-dom_pair	MYL2 CLXN MACF1 PLCB2 MYL10 RYR1	5.68e-04	287	67	6	IPR011992
Domain	HEAT	SCYL2 PRKDC HTT	6.80e-04	48	67	3	PF02985
Domain	EF-hand_6	MYL2 MYL10	9.64e-04	13	67	2	PF13405
Domain	SH3	STAM2 ARHGAP12 MACF1 STAM MCF2L	1.07e-03	216	67	5	PS50002
Domain	SH3_domain	STAM2 ARHGAP12 MACF1 STAM MCF2L	1.16e-03	220	67	5	IPR001452
Domain	HEAT	SCYL2 PRKDC HTT	1.18e-03	58	67	3	IPR000357
Domain	EF_hand_dom	MYL2 CLXN MACF1 MYL10 RYR1	1.46e-03	232	67	5	IPR002048
Domain	AAA+_ATPase	DNAH3 DNAH10 DNAH9 ATP5F1B	1.78e-03	144	67	4	IPR003593
Domain	AAA	DNAH3 DNAH10 DNAH9 ATP5F1B	1.78e-03	144	67	4	SM00382
Domain	UIM	STAM2 STAM	1.87e-03	18	67	2	PF02809
Domain	HEAT_REPEAT	SCYL2 PRKDC HTT	2.03e-03	70	67	3	PS50077
Domain	EFh	MYL2 CLXN MACF1 MYL10	2.50e-03	158	67	4	SM00054
Domain	UIM	STAM2 STAM	2.55e-03	21	67	2	SM00726
Domain	Pentatricopeptide_repeat	PRKDC HTT	3.06e-03	23	67	2	IPR002885
Domain	Spectrin	MACF1 MCF2L	3.06e-03	23	67	2	PF00435
Domain	P-loop_NTPase	DNAH3 DNAH10 MYO6 KIF26A KIF26B DNAH9 AK8 ATP5F1B NLRP13	3.16e-03	848	67	9	IPR027417
Domain	UIM	STAM2 STAM	3.33e-03	24	67	2	PS50330
Domain	UIM_dom	STAM2 STAM	3.61e-03	25	67	2	IPR003903
Domain	EF_Hand_1_Ca_BS	MYL2 CLXN MACF1 MYL10	3.61e-03	175	67	4	IPR018247
Domain	-	STAM2 STAM	3.90e-03	26	67	2	1.25.40.90
Domain	ENTH_VHS	STAM2 STAM	4.84e-03	29	67	2	IPR008942
Domain	Spectrin_repeat	MACF1 MCF2L	4.84e-03	29	67	2	IPR002017
Domain	Spectrin/alpha-actinin	MACF1 MCF2L	5.87e-03	32	67	2	IPR018159
Domain	SPEC	MACF1 MCF2L	5.87e-03	32	67	2	SM00150
Domain	EF_HAND_1	MYL2 CLXN MACF1 MYL10	6.20e-03	204	67	4	PS00018
Domain	GPS	ADGRV1 PKDREJ	6.60e-03	34	67	2	SM00303
Pathway	KEGG_HUNTINGTONS_DISEASE	ATP5PF DNAH3 POLR2E PLCB2 PPARG HTT ATP5F1B	7.24e-06	182	56	7	M13486
Pathway	KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_RETROGRADE_AXONAL_TRANSPORT	DNAH3 DNAH10 DNAH9 HTT	2.95e-05	45	56	4	M47670
Pathway	KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SOD1_TO_RETROGRADE_AXONAL_TRANSPORT	DNAH3 DNAH10 DNAH9	1.62e-04	27	56	3	M47755
Pubmed	Identification, tissue specific expression, and chromosomal localisation of several human dynein heavy chain genes.	DNAH3 DNAH10 DNAH9	2.73e-08	4	67	3	11175280
Pubmed	BioID-based intact cell interactome of the Kv1.3 potassium channel identifies a Kv1.3-STAT3-p53 cellular signaling pathway.	SCYL2 STAM2 PTPN13 MYO6 GCLM ARHGAP12 MACF1 PRKDC STAM ATP5F1B	1.00e-06	708	67	10	39231216
Pubmed	A high-throughput approach for measuring temporal changes in the interactome.	USP14 STAM2 GNE GCLM TRMT112 POLR2E EIF2B2 MACF1 COPS3 PRKDC SIRT1 HTT ATP5F1B	3.51e-06	1455	67	13	22863883
Pubmed	Exploring the mammalian neuromuscular system by analysis of mutations: spinal muscular atrophy and myotonia.	CLCN1 VPS54	3.66e-06	2	67	2	8008830
Pubmed	Sarcolemmal-restricted localization of functional ClC-1 channels in mouse skeletal muscle.	CLCN1 RYR1	3.66e-06	2	67	2	21078869
Pubmed	SIRT1 transcription is decreased in visceral adipose tissue of morbidly obese patients with severe hepatic steatosis.	PPARG SIRT1	3.66e-06	2	67	2	20033348
Pubmed	Sirtuin 1 promotes Th2 responses and airway allergy by repressing peroxisome proliferator-activated receptor-γ activity in dendritic cells.	PPARG SIRT1	3.66e-06	2	67	2	21948987
Pubmed	Resveratrol Regulates the Quiescence-Like Induction of Activated Stellate Cells by Modulating the PPARγ/SIRT1 Ratio.	PPARG SIRT1	3.66e-06	2	67	2	25833683
Pubmed	DNA damage repair kinase DNA-PK and cGAS synergize to induce cancer-related inflammation in glioblastoma.	CGAS PRKDC	3.66e-06	2	67	2	36574362
Pubmed	DNA-PK deficiency potentiates cGAS-mediated antiviral innate immunity.	CGAS PRKDC	3.66e-06	2	67	2	33273464
Pubmed	Sirtuin-1 sensitive lysine-136 acetylation drives phase separation and pathological aggregation of TDP-43.	TARDBP SIRT1	3.66e-06	2	67	2	35264561
Pubmed	Sirt1 inhibits gouty arthritis via activating PPARγ.	PPARG SIRT1	3.66e-06	2	67	2	31367941
Pubmed	Peroxisome proliferator-activated receptor gamma is required for regulatory CD4+ T cell-mediated protection against colitis.	PRKDC PPARG	3.66e-06	2	67	2	17312139
Pubmed	The Function of PPARγ/AMPK/SIRT-1 Pathway in Inflammatory Response of Human Articular Chondrocytes Stimulated by Advanced Glycation End Products.	PPARG SIRT1	3.66e-06	2	67	2	31366866
Pubmed	Colocalization of transactivation-responsive DNA-binding protein 43 and huntingtin in inclusions of Huntington disease.	TARDBP HTT	3.66e-06	2	67	2	19018245
Pubmed	Cyclic GMP-AMP synthase promotes the inflammatory and autophagy responses in Huntington disease.	CGAS HTT	3.66e-06	2	67	2	32581130
Pubmed	Rosiglitazone treatment prevents mitochondrial dysfunction in mutant huntingtin-expressing cells: possible role of peroxisome proliferator-activated receptor-gamma (PPARgamma) in the pathogenesis of Huntington disease.	PPARG HTT	3.66e-06	2	67	2	18640979
Pubmed	Suppression of native defense mechanisms, SIRT1 and PPARγ, by dietary glycoxidants precedes disease in adult humans; relevance to lifestyle-engendered chronic diseases.	PPARG SIRT1	3.66e-06	2	67	2	23636469
Pubmed	From the Cover: l-Carnitine via PPARγ- and Sirt1-Dependent Mechanisms Attenuates Epithelial-Mesenchymal Transition and Renal Fibrosis Caused by Perfluorooctanesulfonate.	PPARG SIRT1	3.66e-06	2	67	2	28973641
Pubmed	Signal-transducing adaptor molecules STAM1 and STAM2 are required for T-cell development and survival.	STAM2 STAM	3.66e-06	2	67	2	12446783
Pubmed	Deubiquitylation and stabilization of Acf7 by ubiquitin carboxylterminal hydrolase 14 (USP14) is critical for NSCLC migration.	USP14 MACF1	3.66e-06	2	67	2	33737492
Pubmed	Striatal-enriched protein tyrosine phosphatase expression and activity in Huntington's disease: a STEP in the resistance to excitotoxicity.	PTPN5 HTT	3.66e-06	2	67	2	21632937
Pubmed	Intracellular signaling for vasoconstrictor coupling factor 6: novel function of beta-subunit of ATP synthase as receptor.	ATP5PF ATP5F1B	3.66e-06	2	67	2	16230521
Pubmed	Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.	STARD13 USP14 TARDBP GNE MYO6 SHCBP1 POLR2E CGAS MACF1 COPS3 PRKDC ATP5F1B	9.47e-06	1353	67	12	29467282
Pubmed	Accelerated activation of SOCE current in myotubes from two mouse models of anesthetic- and heat-induced sudden death.	CASQ2 RYR1	1.10e-05	3	67	2	24143248
Pubmed	TM4SF1 regulates apoptosis, cell cycle and ROS metabolism via the PPARγ-SIRT1 feedback loop in human bladder cancer cells.	PPARG SIRT1	1.10e-05	3	67	2	29175458
Pubmed	Negatively charged amino acids within the intraluminal loop of ryanodine receptor are involved in the interaction with triadin.	CASQ2 RYR1	1.10e-05	3	67	2	14638677
Pubmed	TDP-43 Triggers Mitochondrial DNA Release via mPTP to Activate cGAS/STING in ALS.	TARDBP CGAS	1.10e-05	3	67	2	33031745
Pubmed	SIRT1 is regulated by a PPAR{γ}-SIRT1 negative feedback loop associated with senescence.	PPARG SIRT1	1.10e-05	3	67	2	20660480
Pubmed	Effects of deficiencies of STAMs and Hrs, mammalian class E Vps proteins, on receptor downregulation.	STAM2 STAM	1.10e-05	3	67	2	13679051
Pubmed	Brown remodeling of white adipose tissue by SirT1-dependent deacetylation of Pparγ.	PPARG SIRT1	1.10e-05	3	67	2	22863012
Pubmed	Hybrid structural model of the complete human ESCRT-0 complex.	STAM2 STAM	1.10e-05	3	67	2	19278655
Pubmed	DNA strand breaks and TDP-43 mislocation are absent in the murine hSOD1G93A model of amyotrophic lateral sclerosis in vivo and in vitro.	TARDBP PRKDC	1.10e-05	3	67	2	28832631
Pubmed	Muscle chloride channel dysfunction in two mouse models of myotonic dystrophy.	CLCN1 RYR1	1.10e-05	3	67	2	17158949
Pubmed	Identification of a domain within peroxisome proliferator-activated receptor gamma regulating expression of a group of genes containing fibroblast growth factor 21 that are selectively repressed by SIRT1 in adipocytes.	PPARG SIRT1	1.10e-05	3	67	2	17954559
Pubmed	Association with Hrs is required for the early endosomal localization, stability, and function of STAM.	STAM2 STAM	1.10e-05	3	67	2	15113837
Pubmed	Maternal High-Fat Feeding Increases Placental Lipoprotein Lipase Activity by Reducing SIRT1 Expression in Mice.	PPARG SIRT1	1.10e-05	3	67	2	25948680
Pubmed	Controlling cardiomyocyte length: the role of renin and PPAR-{gamma}.	MYL2 PPARG	1.10e-05	3	67	2	20884641
Pubmed	Cytoplasmic PARP1 links the genome instability to the inhibition of antiviral immunity through PARylating cGAS.	CGAS PRKDC	1.10e-05	3	67	2	35460603
Pubmed	Association of triadin with the ryanodine receptor and calsequestrin in the lumen of the sarcoplasmic reticulum.	CASQ2 RYR1	1.10e-05	3	67	2	7721813
Pubmed	Catalpol Ameliorates Insulin Sensitivity and Mitochondrial Respiration in Skeletal Muscle of Type-2 Diabetic Mice Through Insulin Signaling Pathway and AMPK/SIRT1/PGC-1α/PPAR-γ Activation.	PPARG SIRT1	1.10e-05	3	67	2	32987623
Pubmed	MicroRNA-27a/b-3p and PPARG regulate SCAMP3 through a feed-forward loop during adipogenesis.	SCAMP3 PPARG	1.10e-05	3	67	2	31554889
Pubmed	Differential roles of cardiomyocyte and macrophage peroxisome proliferator-activated receptor gamma in cardiac fibrosis.	MYL2 PPARG	1.10e-05	3	67	2	18511847
Pubmed	N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.	SCYL2 USP14 TARDBP STAM2 PTPN13 MYO6 MACF1 PRKDC STAM ATP5F1B	1.15e-05	934	67	10	33916271
Pubmed	Genetic variation in healthy oldest-old.	PPARG SIRT1 TRDMT1	1.34e-05	24	67	3	19680556
Pubmed	Functional proteomics mapping of a human signaling pathway.	SCYL2 STARD13 STAM2 MYO6 PPP1R3B EXPH5 MACF1 STAM	1.79e-05	591	67	8	15231748
Pubmed	The Vps27/Hrs/STAM (VHS) Domain of the Signal-transducing Adaptor Molecule (STAM) Directs Associated Molecule with the SH3 Domain of STAM (AMSH) Specificity to Longer Ubiquitin Chains and Dictates the Position of Cleavage.	STAM2 STAM	2.19e-05	4	67	2	26601948
Pubmed	Enhanced mitochondrial biogenesis ameliorates disease phenotype in a full-length mouse model of Huntington's disease.	PPARG HTT	2.19e-05	4	67	2	27008868
Pubmed	Next-generation sequencing of small RNAs from inner ear sensory epithelium identifies microRNAs and defines regulatory pathways.	MYO6 ARHGAP12	2.19e-05	4	67	2	24942165
Pubmed	Neurodegeneration-associated TDP-43 interacts with fragile X mental retardation protein (FMRP)/Staufen (STAU1) and regulates SIRT1 expression in neuronal cells.	TARDBP SIRT1	2.19e-05	4	67	2	22584570
Pubmed	GAPDH mediates nitrosylation of nuclear proteins.	PRKDC SIRT1	2.19e-05	4	67	2	20972425
Pubmed	Calcium-binding protein, parvalbumin, is reduced in mutant mammalian muscle with abnormal contractile properties.	CLCN1 VPS54	2.19e-05	4	67	2	6589628
Pubmed	Metabolic stress modulates Alzheimer's β-secretase gene transcription via SIRT1-PPARγ-PGC-1 in neurons.	PPARG SIRT1	2.19e-05	4	67	2	23663737
Pubmed	STAM and Hrs are subunits of a multivalent ubiquitin-binding complex on early endosomes.	STAM2 STAM	2.19e-05	4	67	2	12551915
Pubmed	CACUL1 reciprocally regulates SIRT1 and LSD1 to repress PPARγ and inhibit adipogenesis.	PPARG SIRT1	2.19e-05	4	67	2	29233982
Pubmed	Ubiquitin-specific protease-14 reduces cellular aggregates and protects against mutant huntingtin-induced cell degeneration: involvement of the proteasome and ER stress-activated kinase IRE1α.	USP14 HTT	2.19e-05	4	67	2	24951540
Pubmed	STAM proteins bind ubiquitinated proteins on the early endosome via the VHS domain and ubiquitin-interacting motif.	STAM2 STAM	2.19e-05	4	67	2	12972556
Pubmed	Sirt1 mediates neuroprotection from mutant huntingtin by activation of the TORC1 and CREB transcriptional pathway.	SIRT1 HTT	2.19e-05	4	67	2	22179316
Pubmed	TRIM14 Inhibits cGAS Degradation Mediated by Selective Autophagy Receptor p62 to Promote Innate Immune Responses.	USP14 CGAS	2.19e-05	4	67	2	27666593
Pubmed	Sirtuin1 promotes osteogenic differentiation through downregulation of peroxisome proliferator-activated receptor γ in MC3T3-E1 cells.	PPARG SIRT1	2.19e-05	4	67	2	27378422
Pubmed	Oleic acid activates MMPs up-regulation through SIRT1/PPAR-γ inhibition: a probable linkage between obesity and coronary arterial disease.	PPARG SIRT1	2.19e-05	4	67	2	27072559
Pubmed	Ligand-activated peroxisome proliferator-activated receptor-δ and -γ inhibit lipopolysaccharide-primed release of high mobility group box 1 through upregulation of SIRT1.	PPARG SIRT1	2.19e-05	4	67	2	25275593
Pubmed	STAM adaptor proteins interact with COPII complexes and function in ER-to-Golgi trafficking.	STAM2 STAM	2.19e-05	4	67	2	19054391
Pubmed	Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis.	STARD13 USP14 TARDBP MYL2 MACF1 COPS3 PRKDC RYR1 ATP5F1B	2.40e-05	807	67	9	30575818
Pubmed	Sequence comparison of human and mouse genes reveals a homologous block structure in the promoter regions.	STARD13 CPAMD8 SERPINA1 RAP1GAP CLXN GNE EXPH5 SHCBP1 COPS3 DCT RYR1	3.42e-05	1293	67	11	15342556
Pubmed	Structure and ubiquitin binding of the ubiquitin-interacting motif.	STAM2 STAM	3.64e-05	5	67	2	12750381
Pubmed	Efficient T-cell receptor signaling requires a high-affinity interaction between the Gads C-SH3 domain and the SLP-76 RxxK motif.	STAM2 STAM	3.64e-05	5	67	2	17235283
Pubmed	Activation of a HIF1alpha-PPARgamma axis underlies the integration of glycolytic and lipid anabolic pathways in pathologic cardiac hypertrophy.	MYL2 PPARG	3.64e-05	5	67	2	19490906
Pubmed	PTP1B targets the endosomal sorting machinery: dephosphorylation of regulatory sites on the endosomal sorting complex required for transport component STAM2.	STAM2 STAM	3.64e-05	5	67	2	20504764
Pubmed	Cancer-Cell-Intrinsic cGAS Expression Mediates Tumor Immunogenicity.	CGAS PRKDC	3.64e-05	5	67	2	31665636
Pubmed	Sirt1 promotes fat mobilization in white adipocytes by repressing PPAR-gamma.	PPARG SIRT1	3.64e-05	5	67	2	15175761
Pubmed	Endogenous renal adiponectin drives gluconeogenesis through enhancing pyruvate and fatty acid utilization.	GCGR PPARG	3.64e-05	5	67	2	37848446
Pubmed	Optineurin links myosin VI to the Golgi complex and is involved in Golgi organization and exocytosis.	MYO6 HTT	3.64e-05	5	67	2	15837803
Pubmed	Novel roles for the E3 ubiquitin ligase atrophin-interacting protein 4 and signal transduction adaptor molecule 1 in G protein-coupled receptor signaling.	STAM2 STAM	3.64e-05	5	67	2	22275353
Pubmed	Regulation of epidermal growth factor receptor ubiquitination and trafficking by the USP8·STAM complex.	STAM2 STAM	3.64e-05	5	67	2	20736164
Pubmed	Tyrosine phosphorylation mapping of the epidermal growth factor receptor signaling pathway.	STAM2 STAM	3.64e-05	5	67	2	11687594
Pubmed	Mfn2 ubiquitination by PINK1/parkin gates the p97-dependent release of ER from mitochondria to drive mitophagy.	ATP5PF STAM2 MYO6 STAM	4.13e-05	99	67	4	29676259
Pubmed	A deubiquitinating enzyme UBPY interacts with the Src homology 3 domain of Hrs-binding protein via a novel binding motif PX(V/I)(D/N)RXXKP.	STAM2 STAM	5.46e-05	6	67	2	10982817
Pubmed	Interrupted Glucagon Signaling Reveals Hepatic α Cell Axis and Role for L-Glutamine in α Cell Proliferation.	GCGR PRKDC	5.46e-05	6	67	2	28591638
Pubmed	A cellular system that degrades misfolded proteins and protects against neurodegeneration.	TARDBP HTT	7.63e-05	7	67	2	24882209
Pubmed	Viral infection of the ovaries compromises pregnancy and reveals innate immune mechanisms protecting fertility.	CGAS PRKDC	7.63e-05	7	67	2	34015257
Pubmed	AMSH interacts with ESCRT-0 to regulate the stability and trafficking of CXCR4.	STAM2 STAM	7.63e-05	7	67	2	20159979
Pubmed	Defects in mesenchymal stem cell self-renewal and cell fate determination lead to an osteopenic phenotype in Bmi-1 null mice.	PPARG SIRT1	7.63e-05	7	67	2	19653817
Pubmed	Integration of β-catenin, sirtuin, and FOXO signaling protects from mutant huntingtin toxicity.	SIRT1 HTT	7.63e-05	7	67	2	22956852
Pubmed	SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.	SCYL2 USP14 TARDBP STAM2 PTPN13 PRKDC HTT	9.02e-05	549	67	7	38280479
Pubmed	STAM2, a new member of the STAM family, binding to the Janus kinases.	STAM2 STAM	1.02e-04	8	67	2	10899310
Pubmed	Sequential docking, molecular differentiation, and positioning of T-Tubule/SR junctions in developing mouse skeletal muscle.	CASQ2 RYR1	1.02e-04	8	67	2	11784029
Pubmed	Systematic Analysis of Human Protein Phosphatase Interactions and Dynamics.	PTPN5 MYO6 EXPH5 POLR2E PRKDC ATP5F1B TRDMT1	1.18e-04	573	67	7	28330616
Pubmed	Integrative analysis of kinase networks in TRAIL-induced apoptosis provides a source of potential targets for combination therapy.	SCYL2 ATP5PF SHCBP1 COPS3 PRKDC ATP5F1B	1.25e-04	401	67	6	25852190
Pubmed	Molecular characterization of ENU mouse mutagenesis and archives.	TARDBP HTT	1.30e-04	9	67	2	16139793
Pubmed	Praja1 RING-finger E3 ubiquitin ligase is a common suppressor of neurodegenerative disease-associated protein aggregation.	TARDBP HTT	1.30e-04	9	67	2	35701899
Pubmed	Global proteomics of Ubqln2-based murine models of ALS.	SCYL2 TARDBP STAM2 STAM RYR1	1.51e-04	261	67	5	33277362
Pubmed	RNF43 inhibits WNT5A-driven signaling and suppresses melanoma invasion and resistance to the targeted therapy.	PTPN13 MYO6 EXPH5 MACF1 STAM	1.57e-04	263	67	5	34702444
Pubmed	Candidate gene association study conditioning on individual ancestry in patients with type 2 diabetes and metabolic syndrome from Mexico City.	PPARG SIRT1	1.63e-04	10	67	2	20503258
Pubmed	Dilated cardiomyopathy caused by tissue-specific ablation of SC35 in the heart.	MYL2 CASQ2	1.63e-04	10	67	2	14963485
Pubmed	A forward genetics screen in mice identifies recessive deafness traits and reveals that pejvakin is essential for outer hair cell function.	MYO6 ADGRV1	1.63e-04	10	67	2	17329413
Pubmed	Sexually dimorphic behavior, neuronal activity, and gene expression in Chd8-mutant mice.	THBS2 ANPEP DNAH9	1.76e-04	56	67	3	30104731
Pubmed	Proteomic identification of common SCF ubiquitin ligase FBXO6-interacting glycoproteins in three kinds of cells.	SCYL2 TARDBP MYO6 SCAMP3 COPS3 PRKDC ATP5F1B	1.78e-04	613	67	7	22268729
Pubmed	USP22 regulates lipidome accumulation by stabilizing PPARγ in hepatocellular carcinoma.	PRKDC PPARG	1.99e-04	11	67	2	35449157
Pubmed	Ubiquitin-specific protease 8 deubiquitinates Sec31A and decreases large COPII carriers and collagen IV secretion.	STAM2 STAM	1.99e-04	11	67	2	29604273
Interaction	GJA1 interactions	SCYL2 STAM2 PTPN13 MYO6 CGAS MACF1 SCAMP3 VPS54 STAM HTT ATP5F1B	3.20e-06	583	67	11	int:GJA1
GeneFamily	Dyneins, axonemal	DNAH3 DNAH10 DNAH9	1.24e-05	17	49	3	536
GeneFamily	ESCRT-0	STAM2 STAM	2.15e-05	3	49	2	1115
GeneFamily	Myosin light chains\|EF-hand domain containing	MYL2 MYL10	6.41e-04	14	49	2	657
GeneFamily	Protein tyrosine phosphatases, non-receptor type	PTPN5 PTPN13	1.07e-03	18	49	2	812
GeneFamily	F-type ATPases\|Mitochondrial complex V: ATP synthase subunits	ATP5PF ATP5F1B	1.07e-03	18	49	2	416
GeneFamily	F-type ATPases\|Mitochondrial complex V: ATP synthase subunits	ATP5PF ATP5F1B	1.19e-03	19	49	2	644
GeneFamily	EF-hand domain containing	MYL2 CLXN MACF1 MYL10	2.90e-03	219	49	4	863
GeneFamily	Phospholipases	PLB1 PLCB2	5.78e-03	42	49	2	467
GeneFamily	Kinesins\|Pleckstrin homology domain containing	KIF26A KIF26B	6.90e-03	46	49	2	622
GeneFamily	Rho GTPase activating proteins\|BCH domain containing	STARD13 ARHGAP12	8.11e-03	50	49	2	721
GeneFamily	Armadillo repeat containing\|Protein phosphatase 1 regulatory subunits	PPP1R3B VPS54 RYR1	1.30e-02	181	49	3	694
Coexpression	GSE21063_3H_VS_16H_ANTI_IGM_STIM_BCELL_UP	TARDBP SLC9A9 CFAP300 ADGRV1 PPARG SIRT1	1.24e-05	200	67	6	M8264
Coexpression	GAO_ESOPHAGUS_25W_C1_CILIATED_EPITHELIAL_CELLS	CFAP300 CLXN DNAH10 TMEM151B MACF1 PLCB2 DNAH9 AK8	2.20e-05	459	67	8	M39136
ToppCell	Control-Epithelial-Ciliated\|Control / Disease state, Lineage and Cell class	DNAH3 CFAP300 CLXN DNAH10 DNAH9 AK8	4.09e-07	189	67	6	c007fccd08728db3ea99af9da91d67b9b16dabb3
ToppCell	IPF-Epithelial-Ciliated\|World / Disease state, Lineage and Cell class	DNAH3 CFAP300 CLXN DNAH10 DNAH9 AK8	4.49e-07	192	67	6	d903bbd6c18e29e2c4cdedeb3fea1fd5ad7baa11
ToppCell	IPF-Epithelial-Ciliated\|IPF / Disease state, Lineage and Cell class	DNAH3 CFAP300 CLXN DNAH10 DNAH9 AK8	4.49e-07	192	67	6	354adc1354bf596fbc60dd45c0169688e6f45165
ToppCell	Control-Epithelial-Ciliated\|World / Disease state, Lineage and Cell class	DNAH3 CFAP300 CLXN DNAH10 DNAH9 AK8	4.77e-07	194	67	6	958e648138676d46698090b4046cb484083ae449
ToppCell	COVID-19-Epithelial\|COVID-19 / Condition, Lineage and Cell class	DNAH3 CFAP300 CLXN DNAH10 EXPH5 DNAH9	5.22e-07	197	67	6	18fd7344628a87d5c7ef5efb66e260a4136245bf
ToppCell	Control_saline-Epithelial_airway\|Control_saline / Treatment groups by lineage, cell group, cell type	DNAH3 SERPINA1 ANPEP DNAH10 DNAH9 AK8	5.37e-07	198	67	6	e6863238e022ecfb6a8e3f4b7661b376e92c5d8f
ToppCell	Control_saline-Epithelial_airway-airway_epithelial\|Control_saline / Treatment groups by lineage, cell group, cell type	DNAH3 SERPINA1 ANPEP DNAH10 DNAH9 AK8	5.37e-07	198	67	6	e7aa42e5fbd42c68f50cda4a8f3aa464c862c007
ToppCell	LPS_IL1RA_TNF-Epithelial_airway-airway_epithelial\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	DNAH3 SERPINA1 CFAP300 ANPEP DNAH10 DNAH9	5.70e-07	200	67	6	da12821e8a0657869ca0f75d351cce2d7605a505
ToppCell	distal-3-Hematologic-Platelet/Megakaryocyte\|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	DNAH3 CFAP300 CLXN PKDREJ DNAH9 AK8	5.70e-07	200	67	6	f5f5a8b0e4d802d95dc42646dd5e7d7daaad72b4
ToppCell	LPS_IL1RA_TNF-Epithelial_airway\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	DNAH3 SERPINA1 CFAP300 ANPEP DNAH10 DNAH9	5.70e-07	200	67	6	72c1d9eeaed4b3ee6b6c602e8aa29efc2e8744eb
ToppCell	frontal_cortex-Neuronal-glutamatergic_neuron-L2/3_IT-L2/3_IT_ALM_Macc1_Lrg1\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	SLC9A9 CLXN EXPH5 PPARG RYR1	2.41e-06	142	67	5	d08e1880425d285c4433014fe0242ac7ff7734af
ToppCell	LPS-antiTNF-Epithelial_airway-Ciliated_cells-Ciliated\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DNAH3 CFAP300 CLXN DNAH10 DNAH9	2.95e-06	148	67	5	d61123f0c811287843d066b932b4a9ff09c07c5b
ToppCell	LPS-antiTNF-Epithelial_airway-Ciliated_cells\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DNAH3 CFAP300 CLXN DNAH10 DNAH9	2.95e-06	148	67	5	c8e93b87212f55774223caa385859c566fa1981f
ToppCell	Control-Epithelial_airway-Ciliated_cells-Ciliated\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DNAH3 CLXN DNAH10 DNAH9 AK8	3.58e-06	154	67	5	4e3bc24043144143842627cacf6f90dda2228910
ToppCell	Control-Epithelial_airway-Ciliated_cells\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DNAH3 CLXN DNAH10 DNAH9 AK8	3.58e-06	154	67	5	7556a4b2b062da5ae7ec2bbb66e745e7662db628
ToppCell	LPS-IL1RA+antiTNF-Epithelial_airway-Ciliated_cells\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DNAH3 CFAP300 CLXN DNAH10 DNAH9	3.70e-06	155	67	5	5f1e2195a6b831e1b636f5cc3a282ca423721822
ToppCell	LPS-IL1RA+antiTNF-Epithelial_airway-Ciliated_cells-Ciliated\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DNAH3 CFAP300 CLXN DNAH10 DNAH9	3.70e-06	155	67	5	0944429459f642a1bcc56edc1ec28aaecde3e2dc
ToppCell	Control-Epithelial_airway\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DNAH3 SERPINA1 CLXN ANPEP ADGRV1	4.06e-06	158	67	5	35aee1c3b92169e73569331022833cb44ab7e7e8
ToppCell	LPS-IL1RA+antiTNF-Epithelial_airway\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DNAH3 CFAP300 CLXN ANPEP DNAH9	4.87e-06	164	67	5	e4d4c59aebe5cacd4ecdb907facd044dc82a831d
ToppCell	droplet-Lung-LUNG-30m-Myeloid-Myeloid_Dendritic_Type_2\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ESYT3 SLC9A9 ANPEP PLCB2 RYR1	6.14e-06	172	67	5	a5344760b10ecdc0101f78b93b8fc0f8107068c5
ToppCell	facs-Lung-EPCAM-3m-Myeloid-Myeloid_Dendritic_Type_2\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ESYT3 ANPEP CGAS PLCB2 RYR1	7.25e-06	178	67	5	8c5e9fab7b55a654ccaabf2c4d02397399d94616
ToppCell	Fetal_29-31_weeks-Epithelial-ciliated_cell-D062\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	DNAH3 CLXN DNAH10 DNAH9 AK8	7.25e-06	178	67	5	de5d50d7ca9ee9eb62f50c88a0c6d47f0694b2e6
ToppCell	5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DNAH3 CLXN DNAH10 DNAH9 AK8	7.45e-06	179	67	5	5e5f1cdf4aa66868d45b74ba91e20e848a3cbaff
ToppCell	5'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)-Multiciliated_(nasal)_L.0.3.1.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DNAH3 CFAP300 CLXN DNAH10 DNAH9	7.66e-06	180	67	5	adf5db5bfa9a38b1227ab0beccd8d6f3eea67ac0
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	STARD13 PTPN13 KIF26B SHCBP1 STAM	7.87e-06	181	67	5	b7c85fbef3c06d5dc32a2a58f8d3dfabf1d79d9f
ToppCell	Adult-Epithelial-ciliated_cell-D122\|Adult / Lineage, Cell type, age group and donor	DNAH3 CLXN DNAH10 DNAH9 AK8	8.08e-06	182	67	5	7ded554a4b441e6496db673ba206c0d76ccad7d9
ToppCell	Control-Epithelial_cells-Airway_ciliated\|Control / group, cell type (main and fine annotations)	DNAH3 CLXN DNAH10 DNAH9 AK8	8.08e-06	182	67	5	fb725d10d9ed25dfc6d5bb69cfef78513f7d3e8f
ToppCell	368C-Epithelial_cells-Epithelial-F_(Ciliated)-\|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells)	DNAH3 CFAP300 CLXN DNAH10 DNAH9	8.08e-06	182	67	5	975f6275777fc578eba528e50f69891c66ec44ad
ToppCell	368C-Epithelial_cells-Epithelial-F_(Ciliated)\|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells)	DNAH3 CFAP300 CLXN DNAH10 DNAH9	8.08e-06	182	67	5	f8c28fa76751062c4cfba0db8af1b377f947f739
ToppCell	367C-Epithelial_cells-Epithelial-F_(Ciliated)-\|367C / Donor, Lineage, Cell class and subclass (all cells)	DNAH3 CFAP300 CLXN DNAH10 DNAH9	8.30e-06	183	67	5	b1336eac5adbffade4cef3e0ce3de75a781ae365
ToppCell	COPD-Epithelial-ATII\|World / Disease state, Lineage and Cell class	ESYT3 RAP1GAP PTPN13 MYO6 ADGRV1	8.30e-06	183	67	5	8e9aab4eeec2e282c2cab9bfca6dbf40d660c7b9
ToppCell	367C-Epithelial_cells-Epithelial-F_(Ciliated)\|367C / Donor, Lineage, Cell class and subclass (all cells)	DNAH3 CFAP300 CLXN DNAH10 DNAH9	8.30e-06	183	67	5	cc57dcb59c68d68a546dc108dd9e009b2aab8da5
ToppCell	Children_(3_yrs)-Epithelial-ciliated_cell-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	DNAH3 CLXN DNAH10 DNAH9 AK8	8.52e-06	184	67	5	5daff849625f2f41d56615569c0ed59cd733b34c
ToppCell	COVID-19-Epithelial_cells-Airway_ciliated\|COVID-19 / group, cell type (main and fine annotations)	DNAH3 CLXN DNAH10 DNAH9 AK8	8.75e-06	185	67	5	18a40f0a338aa398d81384b5159fb80ce8a2020c
ToppCell	P28-Epithelial-airway_epithelial_cell-club_cell\|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	DNAH3 CLXN DNAH10 DNAH9 AK8	8.98e-06	186	67	5	a26811481668fa25c48a064a56c198685693ad8d
ToppCell	NS-critical-d_16-33-Epithelial-Ciliated\|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	DNAH3 CFAP300 CLXN DNAH10 DNAH9	8.98e-06	186	67	5	76033438426d8f9c72cd6691a7baf92104c9f03d
ToppCell	P28-Epithelial-airway_epithelial_cell\|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	DNAH3 CLXN DNAH10 DNAH9 AK8	8.98e-06	186	67	5	df80f101954b8ec6ccdb03e702de22e70b65181f
ToppCell	NS-moderate-d_07-13-Epithelial-Ciliated\|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	DNAH3 CFAP300 CLXN DNAH10 DNAH9	8.98e-06	186	67	5	85787ff207f109ec7e3c0f729ba9bda739c2fdc9
ToppCell	COPD-Epithelial-Ciliated\|COPD / Disease state, Lineage and Cell class	DNAH3 CLXN DNAH10 DNAH9 AK8	9.21e-06	187	67	5	f0fd0792f6926f705d175f6e6fd480f12c7a3bd4
ToppCell	COPD-Epithelial-ATII\|Epithelial / Disease state, Lineage and Cell class	STARD13 ESYT3 SERPINA1 RAP1GAP STAM	9.21e-06	187	67	5	030af361f8bdcd0aff4ec1922702833325cf74d8
ToppCell	Fetal_29-31_weeks-Epithelial-ciliated_cell\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	DNAH3 CLXN DNAH10 DNAH9 AK8	9.21e-06	187	67	5	9e10ed56090d82589bc457788282f664b70ace4b
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	CDR2 SERPINA1 EXPH5 ADGRV1 MCF2L	9.21e-06	187	67	5	c41a2c81dd2ceef303f39f699032aa7d6ea67cf0
ToppCell	5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.1\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DNAH3 CFAP300 CLXN DNAH10 DNAH9	9.21e-06	187	67	5	e61992de4f98eeea08b43213850769d923f8db48
ToppCell	Ciliated_cells-B-HP_01\|World / lung cells shred on cell class, cell subclass, sample id	DNAH3 CFAP300 CLXN DNAH10 DNAH9	9.21e-06	187	67	5	bc1f33f332ac939c2425f510173430ca2ba0c3ee
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	STARD13 CPAMD8 PTPN13 SHCBP1 PPARG	9.21e-06	187	67	5	e3095455d2f255854f339f6b05fa87852af0700f
ToppCell	multiciliated\|World / shred by cell class for bronchial biopsy	DNAH3 CFAP300 CLXN DNAH10 DNAH9	9.45e-06	188	67	5	6833c1f0f265ef5448fa65033550ed7efc2f8d7b
ToppCell	Epithelial-ciliated_cell\|World / Lineage, Cell type, age group and donor	DNAH3 CLXN DNAH10 DNAH9 AK8	9.45e-06	188	67	5	61a459f3fe57e5728efc72637ff2edc2d343492b
ToppCell	Adult-Epithelial-ciliated_cell-D231\|Adult / Lineage, Cell type, age group and donor	DNAH3 CLXN DNAH10 DNAH9 AK8	9.45e-06	188	67	5	34b11f72ca73153d02edcd09b38983ad1a504659
ToppCell	Children_(3_yrs)-Epithelial-ciliated_cell\|Children_(3_yrs) / Lineage, Cell type, age group and donor	DNAH3 CLXN DNAH10 DNAH9 AK8	9.45e-06	188	67	5	2b6dfc88be9ded7b88da9fe78a9cd9f9b3af8af3
ToppCell	droplet-Kidney-nan-3m-Epithelial-nan\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ATP5PF RAP1GAP GCGR PKDREJ ATP5F1B	9.45e-06	188	67	5	6b185d0aaeea64f9ae584a9bcb9741658bb1c7bd
ToppCell	COVID-19-lung-Ciliated\|COVID-19 / Disease (COVID-19 only), tissue and cell type	DNAH3 CLXN DNAH10 DNAH9 AK8	9.70e-06	189	67	5	a2da5debd10f27b1280b40141ef0bfef007cc72c
ToppCell	Children_(3_yrs)-Epithelial-ciliated_cell-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	DNAH3 CLXN DNAH10 DNAH9 AK8	9.70e-06	189	67	5	68a3cf7763d6f9b95d6d6524eff7a16042703f1d
ToppCell	cellseq2-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal\|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	DNAH3 CFAP300 CLXN DNAH10 DNAH9	9.70e-06	189	67	5	a3cd4c2da4feb9bdcd8957f3e344d095da1367b8
ToppCell	Multiciliated\|World / shred by cell class for nasal brushing	DNAH3 CFAP300 CLXN DNAH10 DNAH9	9.70e-06	189	67	5	34b110aef839376228c5a403a6b5047a945f472b
ToppCell	Adult-Epithelial-ciliated_cell\|Adult / Lineage, Cell type, age group and donor	DNAH3 CLXN DNAH10 DNAH9 AK8	9.70e-06	189	67	5	b679920f0993e917dd86da082113bfbd85ea1ca5
ToppCell	COVID-19-lung-Ciliated\|lung / Disease (COVID-19 only), tissue and cell type	DNAH3 CLXN DNAH10 DNAH9 AK8	9.70e-06	189	67	5	27329c4661aebabd19fac7fe5dca263fe99d76f3
ToppCell	COPD-Epithelial-Ciliated\|Epithelial / Disease state, Lineage and Cell class	DNAH3 CLXN DNAH10 DNAH9 AK8	9.70e-06	189	67	5	3e77883db34722b9ce0a03ea74caefc92dc7feff
ToppCell	cellseq2-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated\|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	DNAH3 CFAP300 CLXN DNAH10 DNAH9	9.70e-06	189	67	5	93b1026bb1ba759e5704561c9a5de14a30c08894
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	CDR2 SERPINA1 EXPH5 ADGRV1 MCF2L	9.95e-06	190	67	5	1cf023e3c6924d6a06f353d4b62444b6f2fee8a7
ToppCell	Nasal_Brush-Epithelial-Ciliated_2\|Nasal_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X	DNAH3 CFAP300 CLXN DNAH10 DNAH9	9.95e-06	190	67	5	9ce7df056bfb24d70db4c3c4a2c57d89115de877
ToppCell	Nasal_Brush-Epithelial-Ciliated_2\|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X	DNAH3 CFAP300 CLXN DNAH10 DNAH9	9.95e-06	190	67	5	833481ace2800354712e2ce709d5cdfd0aed3d42
ToppCell	cellseq2-Epithelial-Epithelial_Airway\|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	DNAH3 CFAP300 CLXN DNAH10 DNAH9	9.95e-06	190	67	5	17829f4de31b3d9e4d71ba4817d18842aa699773
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	STARD13 PTPN13 SHCBP1 STAM PPARG	9.95e-06	190	67	5	b7f8c2bb9459f1d7c1690069dd5a25a81a57cc84
ToppCell	BAL-Mild-Epithelial-Epithelial-Ciliated-\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	DNAH3 CFAP300 CLXN DNAH10 DNAH9	1.02e-05	191	67	5	2a8e6d560907e71e9f6e190ca0667da804e25641
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2-D150\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	ESYT3 CPAMD8 RAP1GAP PTPN13 ADGRV1	1.02e-05	191	67	5	34cc997e4e5c727495f321e6807a84aa124da486
ToppCell	BAL-Mild-Epithelial-Epithelial-Ciliated-\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	DNAH3 CFAP300 CLXN DNAH10 DNAH9	1.02e-05	191	67	5	46c9d4d10c66c0fae1fa351924091b69ea2f38d4
ToppCell	Mild_COVID-19-Epithelial-Ciliated\|Mild_COVID-19 / Disease group,lineage and cell class （2021.01.30）	DNAH3 CFAP300 CLXN DNAH10 DNAH9	1.02e-05	191	67	5	995e76bbf07674d95b8ef09e078cf6410af27a09
ToppCell	BAL-Mild-Epithelial-Epithelial-Ciliated\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	DNAH3 CFAP300 CLXN DNAH10 DNAH9	1.02e-05	191	67	5	a37f20172b85566b9039254a89680e37fd503fd5
ToppCell	BAL-Mild-Epithelial-Epithelial-Ciliated\|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09)	DNAH3 CFAP300 CLXN DNAH10 DNAH9	1.02e-05	191	67	5	2d36e08c5629cf73b6dd02cd173cafb52e8a3a7d
ToppCell	nucseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	DNAH3 CLXN DNAH10 DNAH9 AK8	1.02e-05	191	67	5	e417bf491f8b8d7838a61f7f4f6b1740ba97aa3f
ToppCell	nucseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	DNAH3 CLXN DNAH10 DNAH9 AK8	1.02e-05	191	67	5	9d31c8424d35bdc0c27188b68bfd0f731af3600b
ToppCell	nucseq-Epithelial-Epithelial_Airway\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	DNAH3 CLXN DNAH10 DNAH9 AK8	1.02e-05	191	67	5	1c528f72c9ef3ef3a850b05e4a9715190832270c
ToppCell	Bronchial_Biopsy-Epithelial-Ciliated_1\|Bronchial_Biopsy / Tissue, Lineage and Cell class of Lung Cells from 10X	DNAH3 CFAP300 CLXN DNAH10 DNAH9	1.05e-05	192	67	5	be592e661367affced9ebe80849b466e6adb3a34
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	ESYT3 RAP1GAP PTPN13 MYO6 ADGRV1	1.05e-05	192	67	5	fb2f0e897228f808d9ff734ad05e9b49dc38fa50
ToppCell	COPD-Epithelial-Ciliated\|World / Disease state, Lineage and Cell class	DNAH3 CLXN DNAH10 DNAH9 AK8	1.05e-05	192	67	5	eab1105cd1a98cfcd3d74dc5c9b89e1799bba59e
ToppCell	3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.3\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DNAH3 CFAP300 CLXN DNAH10 DNAH9	1.07e-05	193	67	5	e1b76102f812c433195d1e8811fdd3293a7bc22e
ToppCell	Control-Epithelial-Ciliated\|Epithelial / Disease state, Lineage and Cell class	DNAH3 CLXN DNAH10 DNAH9 AK8	1.07e-05	193	67	5	0e37d454f3735edd936ee9a5f5f516ac3aad400e
ToppCell	NS-moderate-d_0-4\|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	DNAH3 DNAH10 EXPH5 ADGRV1 DNAH9	1.07e-05	193	67	5	ea345d34440b25f65358a53dc72831998d1c3620
ToppCell	IPF-Epithelial-Ciliated\|Epithelial / Disease state, Lineage and Cell class	DNAH3 CLXN DNAH10 DNAH9 AK8	1.07e-05	193	67	5	ad58f5080e0ba65c845056ea6b79037b636e9c64
ToppCell	Bronchial_Biopsy-Epithelial-Ciliated_1\|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X	DNAH3 CFAP300 CLXN DNAH10 DNAH9	1.07e-05	193	67	5	0b62a6ddd7c42efd9f39781971d1438501e1fa8d
ToppCell	primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	SLC9A9 KIF26B VWA5A ARHGAP12 PPARG	1.07e-05	193	67	5	c4b22b62f3cc7bf0ec0eba76e1504c236290bbc9
ToppCell	Fetal_29-31_weeks-Epithelial\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	CPAMD8 PTPN13 MYO6 EXPH5 ADGRV1	1.07e-05	193	67	5	a0ca3231992f14abcf1a6129573bace320e89d2a
ToppCell	NS-critical-d_07-13-Epithelial-Ciliated\|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	DNAH3 CFAP300 CLXN DNAH10 DNAH9	1.10e-05	194	67	5	1ae8a10e508e672e6677f0e3c986ac30d05adeb3
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Immune-Myeloid-Macrophage_Dendritic-M2_Macrophage\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	STARD13 SLC9A9 PLB1 PLCB2 RYR1	1.10e-05	194	67	5	c95d5c4ad0210ebd672926558cc8331e6396a854
ToppCell	COVID-19-Epithelial-Ciliated_cells\|COVID-19 / Condition, Lineage and Cell class	DNAH3 CFAP300 CLXN DNAH10 DNAH9	1.10e-05	194	67	5	43be5fbd51dd58839cb03ca3ddd05a458e1ddb74
ToppCell	3'-Broncho-tracheal-Epithelial-Airway_ciliated\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DNAH3 CFAP300 CLXN DNAH10 DNAH9	1.13e-05	195	67	5	0e763f36786515698b593e5c93f6a56619c1242d
ToppCell	IPF-Multiplet-Multiplet\|World / Disease state, Lineage and Cell class	DNAH3 CLXN DNAH10 DNAH9 AK8	1.13e-05	195	67	5	21dbdc803c6947024dc2416e9e21c2ef0af9bc31
ToppCell	distal-Epithelial-Proximal_Ciliated\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	DNAH3 CFAP300 CLXN DNAH9 AK8	1.13e-05	195	67	5	abe7998421dc59bdae35c0c2251c4a1ebef5e021
ToppCell	3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DNAH3 CFAP300 CLXN DNAH10 DNAH9	1.13e-05	195	67	5	581b04220587e1d5198b1abd6965965ace7803e7
ToppCell	3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DNAH3 CFAP300 CLXN DNAH10 DNAH9	1.13e-05	195	67	5	93b1559382a12cfb158aa5fac7386e38b4f87989
ToppCell	NS-critical-LOC-Epithelial-Ciliated\|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	DNAH3 CFAP300 CLXN DNAH10 DNAH9	1.13e-05	195	67	5	34e37cff4849696ca4ba5dd8fd2cf98fed8bc912
ToppCell	distal-Epithelial-Proximal_Ciliated-3\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	DNAH3 CFAP300 CLXN DNAH9 AK8	1.13e-05	195	67	5	0e3f74e0877d33c11f048b9be8394596cf5c9c4c
ToppCell	BL-critical-LOC-Epithelial-Ciliated\|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	DNAH3 CFAP300 CLXN DNAH10 DNAH9	1.13e-05	195	67	5	07a6bcef6af93ed87df455dee624037cb75e011a
ToppCell	COVID-19-Epithelial-Ciliated_cells\|Epithelial / Condition, Lineage and Cell class	DNAH3 CFAP300 CLXN DNAH10 DNAH9	1.16e-05	196	67	5	de7aa31354b019d7321a8ef965d59ce2e8b89276
ToppCell	critical-Epithelial-Ciliated\|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	DNAH3 CFAP300 CLXN DNAH10 DNAH9	1.16e-05	196	67	5	27b855c6e1ae44f16db998cf0e81bd686b9cee7e
ToppCell	BAL-Severe-Epithelial-Epithelial-Ciliated\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	DNAH3 CFAP300 CLXN DNAH10 DNAH9	1.16e-05	196	67	5	686a5a0ddb00929842c1c98445c59edfcc9a8a04
ToppCell	BAL-Severe-Epithelial-Epithelial-Ciliated-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	DNAH3 CFAP300 CLXN DNAH10 DNAH9	1.16e-05	196	67	5	67aefc480714e4b8c9ae53c036efdc07ec6f94af
ToppCell	BAL-Severe-Epithelial-Epithelial-Ciliated\|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)	DNAH3 CFAP300 CLXN DNAH10 DNAH9	1.16e-05	196	67	5	ca56311edc6788e032e7635fa69b1e07035202b5
ToppCell	Severe_COVID-19-Epithelial-Ciliated\|Severe_COVID-19 / Disease group,lineage and cell class （2021.01.30）	DNAH3 CFAP300 CLXN DNAH10 DNAH9	1.16e-05	196	67	5	1cdef976a754c90d18b6149d367bd64e6e99b0a9
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Immune-Myeloid-Macrophage_Dendritic\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	STARD13 SLC9A9 PLB1 PLCB2 RYR1	1.16e-05	196	67	5	cbc727b55b6433a701b1a331028a49960fcee6ee
Drug	Biliton	DNAH3 DNAH10 MCF2L DNAH9 SIRT1	1.31e-07	41	67	5	CID000002974
Disease	polycystic kidney disease (implicated_via_orthology)	STAM2 STAM PPARG	4.00e-06	14	67	3	DOID:0080322 (implicated_via_orthology)
Disease	transient cerebral ischemia (biomarker_via_orthology)	PTPN5 PTPN13 PPARG HTT ATP5F1B	2.96e-05	157	67	5	DOID:224 (biomarker_via_orthology)
Disease	Nerve Degeneration	PTPN5 VPS54 PPARG SIRT1	3.90e-05	83	67	4	C0027746
Disease	hypertrophic cardiomyopathy 10 (implicated_via_orthology)	MYL2 MYL10	5.06e-05	5	67	2	DOID:0110316 (implicated_via_orthology)
Disease	Diabetes Mellitus	THBS2 PPARG SIRT1	5.29e-05	32	67	3	C0011849
Disease	glucagon measurement, glucose tolerance test	SERPINA1 MACF1	7.57e-05	6	67	2	EFO_0004307, EFO_0008463
Disease	Acute Kidney Insufficiency	SERPINA1 PPARG SIRT1 ATP5F1B	8.40e-05	101	67	4	C1565662
Disease	Acute kidney injury	SERPINA1 PPARG SIRT1 ATP5F1B	8.40e-05	101	67	4	C2609414
Disease	Kidney Failure, Acute	SERPINA1 PPARG SIRT1 ATP5F1B	8.40e-05	101	67	4	C0022660
Disease	visceral:gluteofemoral adipose tissue ratio measurement	SERPINA1 DNAH10 PPARG	1.48e-04	45	67	3	EFO_0803319
Disease	platelet crit	STARD13 DNAH3 SERPINA1 KIF26A EXPH5 ADGRV1 PPARG DNAJC5B TRDMT1	2.91e-04	952	67	9	EFO_0007985
Disease	very low density lipoprotein cholesterol measurement, cholesteryl esters:total lipids ratio	SERPINA1 DNAH10 MACF1 PPARG HTT	3.39e-04	264	67	5	EFO_0008317, EFO_0020944
Disease	Mood Disorders	SERPINA1 PPARG SIRT1 HTT	5.88e-04	168	67	4	C0525045
Disease	Congenital Fiber Type Disproportion	MYL2 RYR1	7.59e-04	18	67	2	C0546264
Disease	response to methotrexate, neurotoxicity	MACF1 DCT	8.47e-04	19	67	2	EFO_0011057, GO_0031427
Disease	Psychoses, Drug	GCLM GRM2	1.04e-03	21	67	2	C0033937
Disease	Huntington's disease (is_implicated_in)	SIRT1 HTT	1.25e-03	23	67	2	DOID:12858 (is_implicated_in)
Disease	obesity (implicated_via_orthology)	DNAH10 PLCB2 SIRT1 ATP5F1B	1.47e-03	215	67	4	DOID:9970 (implicated_via_orthology)
Disease	very low density lipoprotein cholesterol measurement, cholesterol:total lipids ratio	SERPINA1 MACF1 PPARG HTT	1.65e-03	222	67	4	EFO_0008317, EFO_0020943
Disease	triglyceride measurement, very low density lipoprotein cholesterol measurement	DNAH10 MACF1 PPARG DCT	1.70e-03	224	67	4	EFO_0004530, EFO_0008317
Disease	alkaline phosphatase measurement	SERPINA1 RAP1GAP PPP1R3B EIF2B2 MACF1 PPARG DCT AK8	2.07e-03	1015	67	8	EFO_0004533
Disease	pathological myopia	PPP1R3B DNAJC5B DNAH9	2.08e-03	111	67	3	EFO_0004207
Disease	resting heart rate, chronic obstructive pulmonary disease	PLB1 ADGRV1	2.12e-03	30	67	2	EFO_0000341, EFO_0004351
Disease	aspartate aminotransferase to alanine aminotransferase ratio	SERPINA1 ANPEP STAM PPARG	2.16e-03	239	67	4	EFO_0010934
Disease	very low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio	SERPINA1 MACF1 PPARG HTT	2.16e-03	239	67	4	EFO_0008317, EFO_0020945

Protein segments in the cluster

Peptide	Gene	Start	Entry
LEPLFDETFEFFVPM	ESYT3	816	A0FGR9
DIPFAMFAPKNLELE	ATG13	391	O75143
VLFVKFSMPSVPDFE	COPS3	61	Q9UNS2
PEVKFNKPFVFLMIE	SERPINA1	386	P01009
FARTVPPDFFQAKAM	GRM2	181	Q14416
PPDFFQAKAMAEILR	GRM2	186	Q14416
MPPDLTAFAKQFDIQ	GCLM	196	P48507
MVPFNDDPFGVFILD	ADGRV1	1231	Q8WXG9
FPCFDEPAMKAEFNI	ANPEP	221	P15144
MEKDVDFPVFLQPTN	DNAJC5B	166	Q9UF47
QMVPKFCFPFDVERE	DENND1C	46	Q8IV53
SAPNEFDVMFKLEVP	CGAS	221	Q8N884
KQFAPIHAEAPEFME	ATP5F1B	161	P06576
DPFLLQAEFFEIPMN	PTPN5	296	P54829
QAEFFEIPMNFVDPK	PTPN5	301	P54829
SKEEVDQMFAAFPPD	MYL2	131	P10916
QVPPKMFAFDAVFPQ	KIF26B	501	Q2KJY2
LIQPFFEKEMAVPDS	AK8	316	Q96MA6
PQVPSAQVMDFLFEK	GCGR	21	P47871
FMPPNFPEFAERIEA	MACF1	136	O94854
MTKVPPAFDFSFLND	EXPH5	1	Q8NEV8
VPKMFAFDAVFPQDS	KIF26A	426	Q9ULI4
SEEEVKQMFAAFPPD	MYL10	191	Q9BUA6
KMFFRELPEPLFTFN	ARHGAP12	731	Q8IWW6
DMNTFPTFKFEDPKF	ATP5PF	86	P18859
DFVMAFFKDPNVIPN	CFAP300	61	Q9BRQ4
DFFPPQDIMNKVIGE	HTT	2986	P42858
APIMFGIKTEPEFFE	GNE	26	Q9Y223
NDFKEPYQEMKFFIP	DNAH3	471	Q8TD57
VPFKEPSQSLLEEMF	CDR2	281	Q01850
TFKPFFVDFMLPALI	CPAMD8	801	Q8IZJ3
PAFSEIPDKEFQNVM	MCF2L	101	O15068
FYEPFMDEPIAIPNK	CASQ2	216	O14958
DFNIPKIVTDDMPIF	DNAH9	2076	Q9NYC9
MFKLSPQFPNEEDSF	EIF2B2	271	P49770
LRDMNLPKFVFEDVP	DNAH10	2036	Q8IVF4
KYVQPPMISFEAIFE	DNAH10	3856	Q8IVF4
PCFFQDISMEIPQEF	SCAMP3	146	O14828
LVFDVPILNEFAKMP	RYR1	2626	P21817
VKVFSEFDDPLDMPF	PPP1R3B	76	Q86XI6
RNFFGPEFVKMTIEP	PTPN13	536	Q12923
VADMVKQFFRDLPEP	STARD13	731	Q9Y3M8
FQAPGQVLMEFPKIE	TRDMT1	176	O14717
QMFVFFPEEPKVGIK	POLR2E	71	P19388
KMTFDPEIFFNVLLP	SLC9A9	126	Q8IVB4
KNVDFREFMVAFPDP	TMEM151B	276	Q8IW70
DVMDVFIPKPFRAFA	TARDBP	216	Q13148
EPEFFIDMLYGQPEK	PKDREJ	2216	Q9NTG1
KPFGDFMEPKFEFAV	PPARG	386	P37231
VFQDENTPFVPDMIA	RAP1GAP	296	P47736
DEPLAIMKPEIVFFG	SIRT1	401	Q96EB6
IMKPEIVFFGENLPE	SIRT1	406	Q96EB6
PDADQMTKIPFFDDV	SCYL2	316	Q6P3W7
LQSFMPEGKTFFPEI	SHCBP1	56	Q8NEM2
VVQPFFENVDMPKTS	PLB1	626	Q6P1J6
NFRMDFPFDLKELPA	CLCN1	336	P35523
PKSQMEFEAQVFKDP	CLXN	191	Q9HAE3
EFNPNFVARMIPKVE	TRMT112	36	Q9UI30
ENEIFPSPTEFFMPI	SPATA7	481	Q9P0W8
MPLFATNPFDQDVEK	STAM	1	Q92783
MPLFTANPFEQDVEK	STAM2	1	O75886
NEEKVPLEAFFVFPM	VWA5A	41	O00534
NMVPFFPPVTNEELF	DCT	431	P40126
EPFVFEKILMPELAS	PLCB2	736	Q00722
VPFREMKPVIFLDVF	PRKDC	896	P78527
FDADRPPQLKNMEVF	ZNF862	936	O60290
ETDFRNFQMVPLDPK	THBS2	956	P35442
NTDEPPMVFKAQLFA	USP14	21	P54578
QVPKIFMKPDFALDD	VPS54	161	Q9P1Q0
DFDAPIEEFMSQPEK	NLRP13	291	Q86W25
VFFRPGKFAEFDQIM	MYO6	756	Q9UM54